Graft-Versus-Host Disease: A Review

Barnes DWH Loutit JF . Spleen protection: The cellular hypothesis. In: Bacq ZM , ed. Radiobiology Symposium, Liege. London: Butterworth, 1955: 134

Van Bekkum DW . The selective elimination of immunological competent cells from bone marrow and lymphatic cell mixtures. 1. Effect of storage at 4°C. Transplantation 1964; 2: 393

Trentin JJ Judd KP . Prevention of acute graft versus host mortality with spleen absorbed antithymocyte globulin (ATG). Transplant Proc 1973; 5: 865

Thomas ED Herman EC Greenough WB , Irradiation and marrow infusion in leukaemia. Arch Intern Med 1961; 107: 829

Thomas ED Lochte HL Cannon JH Sahler OD Ferrebee JW . Supralethal whole body irradiation and isologous marrow transplantation in man. J Clin Invest 1959; 38: 1709

McGovern JJ Russell PS Atkins L Webster EW . Treatment of terminal leukaemic relapse by total body irradiation and intravenous infusion of stored autologous bone marrow obtained during remission. N Engl J Med 1959; 260: 675

Bach FH Van Rood JJ . The major histocompatibility complex: Genetics and Biology. N Engl J Med 1976; 295: 806–13, 872–8, 927–36

Storb R Epstein RB Graham TC Thomas ED . Methotrexate regimens for control of graft versus host disease in dogs with allogeneic marrow grafts. Transplantation 1970; 9: 240

Powles RL Clink H Sloan J Barrett AJ Kay HEM McElwain TJ . Cyclosporin A for the treatment of graft versus host disease in man. Lancet 1978; ii: 1327

Prentice HG Blacklock HA Janossy G Skeggs D Bradstock AF Goldstein G . Use of anti-T cell monoclonal antibody OKT3 to prevent acute graft versus host disease in allogeneic bone marrow transplantation for acute leukaemia. Lancet 1982; i: 700

Gluckman E Berger R Dutroix J . Bone marrow transplantation for Fanconi anaemia. Semin Hematol 1984; 21: 20

Barrett AJ . Treatment of Chronic Graft versus host disease. Exp Hematol 1985; 13 (Suppl 17): 135

Lampert IA Janossy G Snitters AJ , Immunological analysis of the skin in graft versus host disease. Clin Exp Immunol 1982; 50: 123

Witherspoon RP Lum LG Storb R . Immunological reconstitution after human marrow grafting. Semin Hematol 1984; 21: 2

Prentice HG Brenner MK Grob JP . T cell depleted HLA-matched allogeneic bone marrow transplantation in the treatment of acute leukemia in first remission. Plasma Ther Transfus Technol 1986; 7: 77–82

Barrett AJ Adams JA Giangrande PLF . Fibroblast colony stimulation in chronic cutaneous graft versus host disease. Exp Hematol 1984; 12: 53–4

Gluckman E Devergie A Sohier J Saurat JH . Graft versus host disease in recipients of syngeneic bone marrow. Lancet 1980; i: 253

Tutschka PJ Belanger R Hess AD Beschorner WE Santos GW . Suppressor cells in transplantation tolerance to self and to non self. Transplant Proc 1983; 15: 853

Muller-Rucholtz W Muller-Hermelink HK Wottge HU . Induction of lasting haemopoietic chimerism in a xenogeneic (rat-mouse) model. Transplant Proc 1979; 11: 517

Bortin MM Rimm AA For the Advisory Committee of the International Bone Marrow Transplant Registry. Allogeneic bone marrow transplantation for 144 patients with severe aplastic anaemia. JAMA 1981; 245: 1135

Kay HEM Lumley H Clink HMcD Powles RL . Ratio of blood and marrow derived cells in bone marrow transplants. J Clin Pathol 1982; 35: 492

Jones JM Wilson R Bealmear PM . Mortality and gross pathology of secondary disease in germ free mouse radiation chimeras. Radiat Res 1971; 45: 577

Van Bekkum DW Knaan S . A role of bacterial microflora in development of intestinal lesions from graft versus host reaction. J Nat Cancer Inst 1977; 58: 787

Vossen JM Heidt PJ Guiot HFL Dooren LJ . Prevention of acute graft versus host disease in clinical bone marrow transplantation: Complete versus selective intestinal decontamination. In: Sasaki eds. Recent advances in germ-free research Tokyo University, 1981: 573

Storb R Prentice L Buckner CD , Graft versus host disease and survival in patients with aplastic anaemia treated by marrow grafts from HLA identical siblings. Beneficial effects of a protective environment. N Engl J Med 1983; 308: 302

Deeg HJ Storb R . Graft versus host disease: Pathophysiological and clinical aspects. Ann Rev Med 1984; 35: 11

Storb R Prentice RL Sullivan KM , Predictive factors in chronic graft versus host disease in patients with aplastic anaemia treated by marrow transplant from HLA identical siblings. Ann Intern Med 1983; 98: 461

Kendra J Barrett AJ Lucas C Joshi R Joss V Desai M Halil O Rogers TR Hobbs JR Hugh-Jones K . Response of graft versus host disease to high doses of methyl prednisolone. Clin Lab Haematol 1981; 3: 19

Sullivan KM Shulman HM Storb R . Chronic graft versus host disease in 52 patients: Adverse natural course and successful treatment with combination immunosuppression. Blood 1981; 57: 267

Storb R Gluckman E Thomas ED , Treatment of established graft versus host disease by antithymocyte globulin. Blood 1974; 44: 57

Ramsay NKC Kersey JH Robinson LL , A randomised study of the prevention of acute graft versus host disease. N Engl J Med 1982; 306: 392

Barrett AJ Kendra JR Lucas CS , Cyclosporin A as prophylaxis against graft versus host disease in 36 patients. Br Med J 1982; 285: 162

Deeg HJ Storb R Thomas ED , Marrow transplantation for acute non-lymphoblastic leukaemia in first remission: Preliminary results for a randomised trial comparing cyclosporin and methotrexate for the prophylaxis of graft versus host disease. Transplant Proc 1983; 15: 1385

Rodt H Kolb HJ Netzel B , The Munich Co-operative Group of BMT. Effect of anti-T cell globulin on GVHD in leukaemic patients treated with BMT. Transplant Proc 1981; 13: 257

Reisner Y Kirkpatrick D Dupont B , Transplantation for acute leukaemia with HLA A and B nonidentical parental marrow cells fractionated with soybean agglutinin and sheep red blood cells. Lancet 1981; ii: 327

Hale G Bright S Chumbley G , Removal of T cells from bone marrow for transplantation: A monoclonal antilymphocyte antibody that fixes human complement. Blood 1983; 62: 873–82

Treleaven JG Gibson FM Ugelstad J Kemshead J . Removal of neuroblastoma cells from bone marrow with monoclonal antibodies conjugated to magnetic microspheres. Lancet 1984; ii: 70–3

Filipovich AH Ramsay NKC Warkentin PI McGlave PB Goldstein G Kersey JH . Pretreatment of donor bone marrow with antibody OKT3 for prevention of GVHD in allogeneic histocompatible BMT. Lancet 1982; i: 1266

Bozdech MJ Sondel PM Trigg ME , Transplantation of HLA haploidentical T-cell depleted marrow for leukaemia: Addition of cytosine arabinoside to the pre-transplant conditioning prevents rejection. Exp Hematol 1985; 13: 1201

Spruce WE McMillan R Miller W , Transplantation of T lymphocyte depleted bone marrow between HLA mismatched individuals. Transplantation 1984; 37: 151

Apperley JF Jones L Hale G , Bone marrow transplantation for patients with chronic myeloid leukaemia: T cell depletion with Campath 1 reduces the incidence of graft versus host disease but may increase the risk of leukaemia relapse. Bone Marrow Transplanttation 1987 (in press)